|
|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 61 - 90 of 251 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
PL
|
Resepti
|
Olanzapin ratiopharm 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg tabletti SPC 2020-07-08
|
|
PL
|
Resepti
|
Olanzapin Ratiopharm 5 mg, 10 mg, 15 mg, 20 mg tabletti, suussa hajoava SPC 2020-09-15
|
|
PL
|
Resepti
|
Olanzapin Sandoz 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg tabletti, kalvopäällysteinen SPC 2021-01-29
|
|
PL
|
Resepti
|
Olanzapine Accord 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg tabletti, kalvopäällysteinen SPC 2022-04-26
|
|
|
|
European Medicines Agency's website:
Olanzapine Apotex - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Olanzapine Glenmark - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Olanzapine Glenmark Europe - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Olanzapine Mylan - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Olanzapine Teva - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Olazax - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Olazax Disperzi - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Oleo D3 14 400 IU-ml tipat, liuos SPC 2021-07-12
|
|
PL
|
Resepti
|
Olimel N12 infuusioneste, emulsio SPC 2020-04-29
|
|
PL
|
Resepti
|
Olimel N12E infuusioneste, emulsio SPC 2020-03-24
|
|
PL
|
Resepti
|
Olimel N5E infuusioneste, emulsio SPC 2020-05-06.docx
|
|
PL
|
Resepti
|
Olimel N7 infuusioneste, emulsio SPC 2020-05-06.docx
|
|
PL
|
Resepti
|
Olimel N7E infuusioneste, emulsio SPC 2020-05-06.docx
|
|
PL
|
Resepti
|
Olimel N9 infuusioneste, emulsio SPC 2020-05-06.docx
|
|
PL
|
Resepti
|
Olimel N9E infuusioneste, emulsio SPC 2020-05-06.docx
|
|
PL
|
Resepti
|
Olimel Perifer N4E infuusioneste, emulsio SPC 2020-05-06.docx
|
|
PL
|
Resepti
|
Olmesartan Medoxomil Accord 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen SPC 2022-09-08
|
|
PL
|
Resepti
|
Olmesartan medoxomil Krka 10 mg, 20 mg, 40 mg, kalvopäällysteinen tabletti SPC 2022-09-27
|
|
PL
|
Resepti
|
Olmesartan medoxomil Sandoz 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen SPC 2022-07-22
|
|
PL
|
Resepti
|
Olmesartan medoxomil Stada 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen SPC 2022-02-04
|
|
PL
|
Resepti
|
Olmesartan medoxomil-Amlodipine Accord 20 mg-5 mg, 40 mg-5 mg, 40 mg-10 mg tabletti, kalvopäällysteinen SPC 2023-01-10
|
|
PL
|
Resepti
|
Olmesartan medoxomil-Amlodipine Krka 20 mg-5 mg, 40 mg-5 mg, 40 mg-10 mg tabletti, kalvopäällysteinen SPC 2022-08-24
|
|
PL
|
Resepti
|
Olmesartan Medoxomil-Hydrochlorothiazide Krka 20 mg-12.5 mg, 20 mg-25 mg tabletti, kalvopäällysteinen SPC 2023-06-09
|
|
PL
|
Resepti
|
Olmesartan Medoxomil-Hydrochlorothiazide Krka 40 mg-12.5 mg, 40 mg-25 mg tabletti, kalvopäällysteinen SPC 2023-06-09
|
|
PL
|
Resepti
|
Oltar 1 mg, 2 mg, 3 mg tabletti SPC 2024-01-23
|
|
|
|
European Medicines Agency's website:
Olumiant - EMA: EPAR PI
Finnish Swedish
|
|
|
| |
